Repeated partial splenic artery embolization for hypersplenism improves platelet count
- PMID: 35574181
- PMCID: PMC9041533
- DOI: 10.1515/med-2022-0479
Repeated partial splenic artery embolization for hypersplenism improves platelet count
Abstract
Splenic embolization is a minimally invasive alternative to splenectomy for the treatment of hypersplenism. This was a retrospective study of 101 patients with hypersplenism caused by cirrhosis who were treated with splenic embolization and for whom 6 months of follow-up data were available. Of these patients, 65 underwent partial splenic artery embolization (PSE), including 23 who underwent repeated PSE (RPSE). The incidence of abdominal pain was significantly higher in the PSE group than in the total splenic artery embolization (TSE) group (P < 0.001), and its duration was also longer in the PSE group (P = 0.003). Biochemical markers of liver function were compared before and after the operation; aminotransferase indices decreased (alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase), total bilirubin increased slightly, and albumin and prealbumin decreased after the operation (all P < 0.001). Platelet (PLT) counts began to increase at 1 week postoperatively, peaked at 1 month postoperatively, and then decreased gradually. There was no significant intergroup (PSE and TSE) difference at any time point (1 day, 1 week, 1 month, and 6 months postoperatively, P > 0.05). There was a significant intergroup (PSE and RPSE) difference in the mean postoperative change in PLT count (P = 0.45). Splenic embolization can improve the inflammatory indicators of liver function. Performing PSE twice or more improves the PLT counts.
Keywords: liver function; partial splenic embolization; platelet count; side effect; splenic abscess.
© 2022 Youwen Tan et al., published by De Gruyter.
Conflict of interest statement
Conflict of interest: The authors declare that they have no conflict of interest.
Figures



Similar articles
-
Analysis of the efficacy of splenic artery superselective embolization in cirrhosis with hepatocellular carcinoma.PLoS One. 2025 May 28;20(5):e0323829. doi: 10.1371/journal.pone.0323829. eCollection 2025. PLoS One. 2025. PMID: 40435313 Free PMC article.
-
Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients.World J Surg. 2009 Aug;33(8):1702-10. doi: 10.1007/s00268-009-0095-2. World J Surg. 2009. PMID: 19513783 Clinical Trial.
-
Efficacy and safety of heparin plus dexamethasone after partial splenic embolization for liver cirrhosis with massive splenomegaly.BMC Gastroenterol. 2022 Nov 19;22(1):470. doi: 10.1186/s12876-022-02580-8. BMC Gastroenterol. 2022. PMID: 36402985 Free PMC article.
-
Clinical benefits of partial splenic embolization for cancer patients.Hepatol Res. 2025 Jan;55(1):4-11. doi: 10.1111/hepr.14142. Epub 2024 Nov 30. Hepatol Res. 2025. PMID: 39614706 Review.
-
Partial splenic artery embolization in cirrhotic patients.World J Radiol. 2014 May 28;6(5):160-8. doi: 10.4329/wjr.v6.i5.160. World J Radiol. 2014. PMID: 24876920 Free PMC article. Review.
Cited by
-
Analysis of the efficacy of splenic artery superselective embolization in cirrhosis with hepatocellular carcinoma.PLoS One. 2025 May 28;20(5):e0323829. doi: 10.1371/journal.pone.0323829. eCollection 2025. PLoS One. 2025. PMID: 40435313 Free PMC article.
-
Uncommon Presentation of Hypersplenism in Adult Sickle Cell Disease Patients: A Rare Case Report.Am J Case Rep. 2024 Sep 20;25:e944693. doi: 10.12659/AJCR.944693. Am J Case Rep. 2024. PMID: 39300742 Free PMC article.
-
Efficacy and Safety of Transarterial Chemoembolization and Repeated Partial Splenic Embolization for Hepatocellular Carcinoma with Hypersplenism and Thrombocytopenia.J Hepatocell Carcinoma. 2024 Jun 11;11:1065-1078. doi: 10.2147/JHC.S455461. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 38882439 Free PMC article.
-
Will partial splenic embolization followed by splenectomy increase intraoperative bleeding?World J Gastrointest Surg. 2024 Feb 27;16(2):318-330. doi: 10.4240/wjgs.v16.i2.318. World J Gastrointest Surg. 2024. PMID: 38463347 Free PMC article.
-
Colosplenic Fistula Following Splenic Embolization in a Sickle Cell Disease Patient.Cureus. 2024 May 24;16(5):e61011. doi: 10.7759/cureus.61011. eCollection 2024 May. Cureus. 2024. PMID: 38800766 Free PMC article.
References
-
- McCormick PA, Murphy KM. Splenomegaly, hypersplenism and coagulation abnormalities in liver disease. Baillieres Best Pract Res Clin Gastroenterol. 2000 Dec;14(6):1009–31. - PubMed
-
- Wu Y, Li H, Zhang T, Bai Z, Xu X, Levi Sandri GB, et al. Splanchnic vein thrombosis in liver cirrhosis after splenectomy or splenic artery embolization: a systematic review and meta-analysis. Adv Ther. 2021 Apr;38(4):1904–30. - PubMed
-
- Wang YB, Zhang JY, Zhang F, Zhao Y, Gong JP. Partial splenic artery embolization to treat hypersplenism secondary to hepatic cirrhosis: a meta-analysis. Am Surg. 2017 Mar 1;83(3):274–83. - PubMed
-
- Amin MA, el-Gendy MM, Dawoud IE, Shoma A, Negm AM, Amer TA. Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients. World J Surg. 2009 Aug;33(8):1702–10. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials